Elliot J Rayfield, MD
- CLINICAL PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Specialty:Endocrine, Diabetes and Bone Diseases
Dr. Elliot J. Rayfield is a Clinical Professor of Medicine (Endocrinology, Diabetes, and Bone Diseases). He is Board Certified in Internal Medicine and Endocrinology and Metabolism. Dr. Rayfield was President of the American Diabetes Association (New York Downstate Affiliate). He is a Member of the American Society for Clinical Research and a Fellow of the American College of Physicians. He has been active on national committees of the American Diabetes Association, The Endocrine Society, and the American College of Clinical Endocrinology where he serves on the Editorial Board of Endocrine Practice. He focuses on preventative endocrinology
American Board of Internal Medicine
MD, Jefferson Medical College
Residency, Internal Medicine, University of Michigan Hospitals
Fellowship, Endocrinology, Harvard Medical School
Fellowship, Endocrinology, Brigham and Women's Hospital
Sidney H. Ingbar Distinguished Service Award
The Jacobi Medallion
First Professional Education Service Award
Fifth Annual Distinguished Research Award, Department of Medicine
American Diabetes Association Research and Development Award
NIH Research Career Development Award
Alpha Omega Alpha
Galati S, Rayfield E. Approach to the patient with postprandial hypoglycemia. Endocrine Practice 2014; 20: 331-340.
Rayfield E. Clark T Sawin Library and Resource Center: An Update. Endocrine News 2010 September;.
Rayfield E. Evidence-Based Medicine-GAPPNETTM and its Role in Patient Care. Insulin 2010; 5: 74-76.
Magnotti M, Rayfield E. The HumaPenR Luxura TM HD Pen-- What Is the Role of 0.5-Unit Insulin Dosing? . Journal of Diabetes Science and Technology 2010 March; 4.
Rayfield E. Evidence-Based Medicine-A Brief Review. Insulin 2010; 5: 7-10.
Potenza M, Rayfield E. Targeting the Incretin System in Type 2 Diabetes. Mount Sinai Journal of Medicine 2009;.
Farkouh M, Rayfield E, Fuster V. Diabetes and Cardiovascular Disease. In: The Heart (Thirteenth Edition). pp2028-2058.
LeRoith D, Rayfield E. The benefits of tight glycemic control in type 2 diabetes mellitus. Clinical Cornerstone 2007; 8(Suppl. 7): S19-S29.